Medsubone Ltd in London, SW1P 4QP

Description

Data updated on: 01-11-2023

Medsubone has been operating in this business field for 5 years. Registered under company registration number 12309662, this company is considered a Private Limited Company. You may visit the main office of this firm during its opening times at the following address: 13th Floor Millbank Tower 21-24 Millbank, SW1P 4QP London. The enterprise's principal business activity number is 62090 which means Other information technology service activities. Medsubone Limited reported its account information for the period up to 2022-12-31. The latest annual confirmation statement was submitted on 2022-11-11.

Right now, this limited company is controlled by a solitary director: Danoosh V., who was appointed in 2019.

The companies with significant control over this firm include: Huma Therapeutics Limited owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in London at Millbank Tower, 21-24 Millbank, SW1P 4QP and was registered as a PSC under the reg no 07725451.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2020-12-31	2021-12-31	2022-12-31
Currency

Balance Sheet
Cash Bank On Hand	48 763	129 589	134 204
Current Assets	71 372	137 135	134 331
Debtors	22 609	7 546	127
Other Debtors	22 609	7 546	127
Property Plant Equipment	8 441

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets	323 150	323 150
Accumulated Depreciation Impairment Property Plant Equipment	3 781
Administrative Expenses		44 071	3 074
Amounts Owed To Group Undertakings	1 071 183	1 777	1 777
Average Number Employees During Period	7	2	2
Comprehensive Income Expense		83 672	-3 044
Creditors	28 127	1 777	2 017
Disposals Decrease In Amortisation Impairment Intangible Assets			323 150
Disposals Decrease In Depreciation Impairment Property Plant Equipment		3 781
Disposals Intangible Assets			323 150
Disposals Property Plant Equipment		12 222
Fixed Assets	8 441
Gain Loss On Disposals Property Plant Equipment		-3 458
Gain Loss On Non-financing Activities Due To Foreign Exchange Differences Recognised In Profit Or Loss		44	1
Increase From Depreciation Charge For Year Property Plant Equipment	3 781
Intangible Assets Gross Cost	323 150	323 150
Interest Expense On Bank Overdrafts		45
Interest Payable Similar Charges Finance Costs		66
Net Current Assets Liabilities	-1 026 161	135 358	132 314
Number Shares Issued Fully Paid			1
Operating Profit Loss		-44 071	-3 074
Other Creditors	10 744
Other Interest Receivable Similar Income Finance Income		9	30
Other Investments Other Than Loans	-1
Par Value Share			1
Pension Other Post-employment Benefit Costs Other Pension Costs		2 528
Profit Loss		83 672	-3 044
Profit Loss On Ordinary Activities Before Tax		-44 128	-3 044
Property Plant Equipment Gross Cost	12 222
Social Security Costs		24 020
Staff Costs Employee Benefits Expense		222 547
Tax Tax Credit On Profit Or Loss On Ordinary Activities		-127 800
Total Additions Including From Business Combinations Intangible Assets	323 150
Total Additions Including From Business Combinations Property Plant Equipment	12 222
Total Assets Less Current Liabilities	51 686	135 358	132 314
Trade Creditors Trade Payables	15 606		240

Company staff

Danoosh V.

Role: Director

Appointed: 12 November 2019

Latest update: 10 April 2024

People with significant control

Huma Therapeutics Limited

Address: 21-24 Millbank Millbank Tower, 21-24 Millbank, London, SW1P 4QP, United Kingdom

Legal authority Companies Act 2006

Legal form Private Company Limited By Shares

Country registered United Kingdom

Place registered Uk Register Of Companies

Registration number 07725451

Notified on 12 November 2019

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	25 November 2023
Confirmation statement last made up date	11 November 2022

Annual Accounts
Start Date For Period Covered By Report	12 November 2019
End Date For Period Covered By Report	31 December 2020
Annual Accounts
Start Date For Period Covered By Report	01 January 2021
End Date For Period Covered By Report	31 December 2021
Annual Accounts
End Date For Period Covered By Report	31 December 2022

Medsubone Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Danoosh V.

People with significant control

Huma Therapeutics Limited

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode